HAO; Jinsong

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAO; Jinsong.The latest application filed is for "bicycloheptane pyrrolidine orexin receptor agonists".

Company Profile

3.11.14

HAO; Jinsong - Belle Meade NJ
Hao; Jinsong - Belle Mead NJ
Hao; Jinsong - Kenilworth NJ
Hao; Jinsong - Singapore SG

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicycloheptane Pyrrolidine Orexin Receptor Agonists App 20220056017 - BOGEN; Stephane L. ; et al.	2022-02-24
Antidiabetic heterocyclic compounds Grant 11,072,602 - Miller , et al. July 27, 2	2021-07-27
Antidiabetic spirochroman compounds Grant 10,968,232 - Miller , et al. April 6, 2	2021-04-06
Antidiabetic Heterocyclic Compounds App 20190367495 - Miller; Michael ; et al.	2019-12-05
Antidiabetic Spirochroman Compounds App 20190337961 - Miller; Michael ; et al.	2019-11-07
Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes Grant 8,722,882 - Neustadt , et al. May 13, 2	2014-05-13
Amino-quinoxaline and amino-quinoline compounds for use as adenosine A.sub.2a receptor antagonists Grant 8,415,353 - Harris , et al. April 9, 2	2013-04-09
1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-3-one compounds for use as adenosine A.sub.2a receptor antagonists Grant 8,222,259 - Harris , et al. July 17, 2	2012-07-17
Bridged Bicyclic Heterocycle Derivatives And Methods Of Use Thereof App 20120040975 - Neelamkavil; Santhosh Francis ; et al.	2012-02-16
Pyrimidine Derivatives As Gpcr Modulators For Use In The Treatment Of Obesity And Diabetes App 20110263570 - Neustadt; Bernard R. ; et al.	2011-10-27
1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE AND PYRAZOLO[4,3-e]-1,2,4-TRIAZOLO[4,3-c]PYRIMIDIN-3-ONE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS App 20110152256 - Harris; Joel M. ; et al.	2011-06-23
Bicyclic Heterocycle Derivatives And Their Use As Gpcr Modulators App 20110118286 - Neelamkavil; Santhosh Francis ; et al.	2011-05-19
AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS App 20110105513 - Harris; Joel M. ; et al.	2011-05-05
Bicyclic Heterocycle Derivatives And Use Thereof As Gpr119 Modulators App 20110065671 - Harris; Joel M. ; et al.	2011-03-17
Pyrimidinone Derivatives And Methods Of Use Thereof App 20100190687 - Boyle; Craig D. ; et al.	2010-07-29
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A.sub.2a receptor antagonists Grant 7,709,492 - Neustadt , et al. May 4, 2	2010-05-04
2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A.sub.2a receptor antagonists Grant 7,368,449 - Neustadt , et al. May 6, 2	2008-05-06
Topical and/or transdermal bioactive compound delivery system App 20060067995 - Heng; Wan Sia Paul ; et al.	2006-03-30
Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists App 20050239795 - Neustadt, Bernard R. ; et al.	2005-10-27
2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists App 20050222164 - Neustadt, Bernard R. ; et al.	2005-10-06
2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists Grant 6,897,217 - Neustadt , et al. May 24, 2	2005-05-24
2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists App 20040220194 - Neustadt, Bernard R. ; et al.	2004-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.